Altered Sphingolipid Metabolism inN-(4-Hydroxyphenyl)- retinamide-resistant A2780 Human Ovarian Carcinoma Cells*

In the present work, we studied the effects of fenretinide (N-(4-hydroxyphenyl)retinamide (HPR)), a hydroxyphenyl derivative of all-trans-retinoic acid, on sphingolipid metabolism and expression in human ovarian carcinoma A2780 cells. A2780 cells, which are sensitive to a pharmacologically achievable HPR concentration, become 10-fold more resistant after exposure to increasing HPR concentrations. Our results showed that HPR was able to induce a dose- and time-dependent increase in cellular ceramide levels in sensitive but not in resistant cells. This form of resistance in A2780 cells was not accompanied by the overexpression of multidrug resistance-specific proteins MDR1 P-glycoprotein and multidrug resistance-associated protein, whose mRNA levels did not differ in sensitive and resistant A2780 cells. HPR-resistant cells were characterized by an overall altered sphingolipid metabolism. The overall content in glycosphingolipids was similar in both cell types, but the expression of specific glycosphingolipids was different. Specifically, our findings indicated that glucosylceramide levels were similar in sensitive and resistant cells, but resistant cells were characterized by a 6-fold lower expression of lactosylceramide levels and by a 6-fold higher expression of ganglioside levels than sensitive cells. The main gangliosides from resistant A2780 cells were identified as GM3 and GM2. The possible metabolic mechanisms leading to this difference were investigated. Interestingly, the mRNA levels of glucosylceramide and lactosylceramide synthases were similar in sensitive and resistant cells, whereas GM3 synthase mRNA level and GM3 synthase activity were remarkably higher in resistant cells.

[1]  J. Kok,et al.  Altered sphingolipid metabolism in multidrug‐resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  C. Ohyama,et al.  Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer. , 2002, Cancer research.

[3]  W-X Guo,et al.  N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes , 2002, Leukemia.

[4]  C. Ohyama,et al.  Glycolipid composition in bladder tumor: A crucial role of GM3 ganglioside in tumor invasion , 2001, International journal of cancer.

[5]  M. Cabot,et al.  N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase. , 2001, Cancer research.

[6]  N. Loberto,et al.  Changes in the Lipid Turnover, Composition, and Organization, as Sphingolipid-enriched Membrane Domains, in Rat Cerebellar Granule Cells Developing in Vitro * , 2001, The Journal of Biological Chemistry.

[7]  R. Pergolizzi,et al.  Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarianumour cell line , 2001, British Journal of Cancer.

[8]  D. Delia,et al.  Up‐regulation of prosaposin by the retinoid HPR and the effect on ceramide production and integrin receptors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  J. Kok,et al.  The Involvement of Sphingolipids in Multidrug Resistance , 2001, The Journal of Membrane Biology.

[10]  M. Cabot,et al.  Targeting ceramide metabolism--a strategy for overcoming drug resistance. , 2001, Journal of the National Cancer Institute.

[11]  A. Giuliano,et al.  Ceramide glycosylation potentiates cellular multidrug resistance , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  L. Riboni,et al.  Biomodulatory role of ceramide in basic fibroblast growth factor‐induced proliferation of cerebellar astrocytes in primary culture , 2000, Glia.

[13]  J. Kok,et al.  Differential expression of sphingolipids in MRP1 overexpressing HT29 cells , 2000, International journal of cancer.

[14]  S. Sonnino,et al.  Sphingolipid-enriched Membrane Domains from Rat Cerebellar Granule Cells Differentiated in Culture , 2000, The Journal of Biological Chemistry.

[15]  U. Reichert,et al.  Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid. , 2000, Blood.

[16]  A. Giuliano,et al.  Uncoupling Ceramide Glycosylation by Transfection of Glucosylceramide Synthase Antisense Reverses Adriamycin Resistance* , 2000, The Journal of Biological Chemistry.

[17]  M. Sporn,et al.  Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. , 1999, Journal of the National Cancer Institute.

[18]  A. Giuliano,et al.  Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis. , 1999, Experimental cell research.

[19]  M. Cabot,et al.  Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. , 1999, Journal of the National Cancer Institute.

[20]  R. Pergolizzi,et al.  Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells , 1999, International journal of cancer.

[21]  S. Sonnino,et al.  A procedure for the preparation of GM3 ganglioside from GM1-lactone , 1999, Glycoconjugate Journal.

[22]  A. Futerman,et al.  Up-regulation of Neutral Glycosphingolipid Synthesis upon Long Term Inhibition of Ceramide Synthesis by Fumonisin B1 * , 1999, The Journal of Biological Chemistry.

[23]  A E Giuliano,et al.  Expression of Glucosylceramide Synthase, Converting Ceramide to Glucosylceramide, Confers Adriamycin Resistance in Human Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[24]  Y. Hannun,et al.  The role of ceramide in cell signaling. , 1998, Biochimica et biophysica acta.

[25]  Jcbn.  Nomenclature of glycolipids , 1998 .

[26]  A. Sabichi,et al.  Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. , 1998, Journal of the National Cancer Institute.

[27]  L. Riboni,et al.  The role of sphingolipids in the process of signal transduction. , 1997, Progress in lipid research.

[28]  R. Lotan,et al.  Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. , 1997, Journal of the National Cancer Institute.

[29]  John Calvin Reed,et al.  Role of antioxidants and intracellular free radicals in retinamide-induced cell death. , 1997, Carcinogenesis.

[30]  A. Giuliano,et al.  Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells* , 1997, The Journal of Biological Chemistry.

[31]  S. Hakomori.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.

[32]  A. Giuliano,et al.  Tamoxifen retards glycosphingolipid metabolism in human cancer cells , 1996, FEBS letters.

[33]  A. Fanjul,et al.  4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors* , 1996, The Journal of Biological Chemistry.

[34]  S. Sonnino,et al.  Metabolic Processing of Gangliosides by Normal and Salla Human Fibroblasts in Culture , 1996, The Journal of Biological Chemistry.

[35]  A E Giuliano,et al.  Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells* , 1996, The Journal of Biological Chemistry.

[36]  R. Lotan.  Retinoids in cancer chemoprevention , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  F. Formelli,et al.  Bioactivities of N‐(4‐hydroxyphenyl) retinamide and retinoyl β‐glucuronide , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  S. Sonnino,et al.  Evaluation of the efficiency of an assay procedure for gangliosides in human serum , 1996, Glycoconjugate Journal.

[39]  A. Bielawska,et al.  (1S,2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol as an Inhibitor of Ceramidase (*) , 1996, The Journal of Biological Chemistry.

[40]  F. Zunino,et al.  Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression , 1996, International journal of cancer.

[41]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[42]  L. Riboni,et al.  A Mediator Role of Ceramide in the Regulation of Neuroblastoma Neuro2a Cell Differentiation (*) , 1995, The Journal of Biological Chemistry.

[43]  C. Boni,et al.  Can fenretinide protect women against ovarian cancer? , 1995, Journal of the National Cancer Institute.

[44]  F. Zunino,et al.  Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance. , 1994, Molecular pharmacology.

[45]  H. Tsou,et al.  Down-Regulation of Retinoic Acid Receptor 3 in Mammary Carcinoma Cell Lines and Its Up-Regulation in Senescing Normal Mammary Epithelial Cells 1 , 2005 .

[46]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[47]  B. Houle,et al.  Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Sonnino,et al.  Formation of free sphingosine and ceramide from exogenous ganglioside GM1 by cerebellar granule cells in culture , 1992, FEBS letters.

[49]  D. Scudiero,et al.  Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. , 1991, Journal of the National Cancer Institute.

[50]  S. Hakomori,et al.  A facile and regiospecific tritiation of sphingosine: Synthesis of (2S,3R,4E)‐2‐amino‐4‐octadecene‐1,3‐diol‐1‐3H , 1991 .

[51]  Domenico Acquotti,et al.  Three-dimensional structure of the oligosaccharide chain of GM1 ganglioside revealed by a distance-mapping procedure: a rotating and laboratory frame nuclear overhauser enhancement investigation of native glycolipid in dimethyl sulfoxide and in water-dodecylphosphocholine solutions , 1990 .

[52]  M. Masserini,et al.  Specific tritium labeling of gangliosides at the 3-position of sphingosines. , 1981, Journal of lipid research.

[53]  F. Bonali,et al.  A new procedure for the extraction, purification and fractionation of brain gangliosides. , 1973, Biochimica et biophysica acta.

[54]  E. Kostetsky,et al.  Modified spray for the detection of phospholipids on thin-layer chromatograms. , 1968, Journal of lipid research.

[55]  C. Sweeley,et al.  Chemistry and metabolism of sphingolipids. 3-Oxo derivatives of N-acetylsphingosine and N-acetyldihydrosphingosine. , 1966, Journal of the American Chemical Society.

[56]  Herbert E. Carter,et al.  Biochemistry of the sphingolipids: XII. conversion of cerebrosides to ceramides and sphingosine; structure of Gaucher cerebroside , 1961 .

[57]  G. R. Bartlett.  Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.

[58]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[59]  L. Obeid,et al.  Ceramidases in the regulation of ceramide levels and function. , 2002, Sub-cellular biochemistry.

[60]  N. Radin,et al.  Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? , 2001, European journal of biochemistry.

[61]  K. Sandhoff,et al.  In vitro assays for enzymes of ganglioside synthesis. , 2000, Methods in enzymology.

[62]  A. Giuliano,et al.  Glucosylceramide: a marker for multiple-drug resistant cancers. , 1998, Anticancer research.

[63]  L. Nagy,et al.  Retinoid-induced apoptosis in normal and neoplastic tissues , 1998, Cell Death and Differentiation.

[64]  M. Chester.  Nomenclature of Glycolipids (IUPAC Recommendations 1997) , 1997 .

[65]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[66]  S M Partridge,et al.  Filter-paper partition chromatography of sugars: 1. General description and application to the qualitative analysis of sugars in apple juice, egg white and foetal blood of sheep. with a note by R. G. Westall. , 1948, The Biochemical journal.